Ikhithi yokuFumanisa utshintsho lwe-EGFR Gene 29 yabantu (i-Fluorescence PCR)-RUO

Inkcazo emfutshane:

[Ikhowudi yeMveliso] HWTS- TM4008

Inkcazo emfutshane

Le khithi isetyenziselwa ukubona ngokwe-vitro utshintsho oluqhelekileyo kwi-exons 18-21 ye-EGFR gene kwiisampuli ezivela kwizigulane zomhlaza wemiphunga ezingezizo iiseli ezincinci zabantu (jonga iTheyibhile 1 ukuze ufumane iinkcukacha).

Ukusetyenziswa koPhando Kuphela


Iinkcukacha zeMveliso

Iithegi zeMveliso

Igama lemveliso

Ikhithi yokuFumanisa utshintsho lwe-EGFR Gene 29 yabantu (i-Fluorescence PCR)-RUO

I-Epidemiology

Umhlaza wemiphunga uye waba ngunobangela ophambili wokufa komhlaza kwihlabathi liphela, nto leyo esongela kakhulu impilo yabantu. Umhlaza wemiphunga ongengoweeseli ezincinci ubandakanya malunga ne-80%-85% yezigulana ezinomhlaza wemiphunga. I-EGFR okwangoku yeyona nto iphambili ekujoliswe kuyo kunyango lomhlaza wemiphunga ongengoweeseli ezincinci. I-phosphorylation ye-EGFR inokukhuthaza ukukhula kweeseli ze-tumor, ukwahluka, ukuhlasela, ukusasazeka kwe-metastasis, ukulwa ne-apoptosis, kunye nokukhuthaza i-tumor angiogenesis. I-EGFR tyrosine kinase inhibitors (TKI) inokuthintela indlela yokubonisa i-EGFR ngokuthintela i-EGFR autophosphorylation, ngaloo ndlela ithintela ukwanda kunye nokwahlukana kweeseli ze-tumor, ikhuthaza i-tumor cell apoptosis, inciphisa i-tumor angiogenesis, njl.njl., ukuze kufezekiswe unyango olujoliswe kwi-tumor [1]. Inani elikhulu lezifundo libonise ukuba ukusebenza kakuhle kwe-EGFR-TKI kunxulumene kakhulu nesimo sokuguqulwa kwe-gene ye-EGFR, kwaye kunokuthintela ngokukodwa ukukhula kweeseli ze-tumor nge-gene mutation ye-EGFR [2,3]. I-EGFR gene ikwingalo emfutshane ye-chromosome 7 (7p12), ubude bayo buyi-200Kb kwaye inama-exons angama-28. Indawo yokuguqulwa kwezakhi zofuzo ifumaneka kakhulu kwi-exons 18 ukuya kwi-21, i-codons 746 ukuya kwi-753 deletion mutation kwi-exon 19 imalunga ne-45% kwaye i-L858R mutation kwi-exon 21 imalunga ne-40% ukuya kwi-45% [4]. Izikhokelo ze-NCCN zoKuxilonga kunye nokuNyangwa koMhlaza weMiphunga weNon-Small Cell Lung Cancer zichaza ngokucacileyo ukuba uvavanyo lokuguqulwa kwezakhi zofuzo lwe-EGFR luyadingeka ngaphambi kokunikezelwa kwe-EGFR-TKI. Le khithi yovavanyo isetyenziselwa ukukhokela ukunikezelwa kwamayeza okukhula kwe-epidermal factor receptor tyrosine kinase inhibitor (EGFR-TKI), kwaye ibonelela ngesiseko sonyango oluqondene nawe kwizigulane ezinomhlaza wemiphunga we-non-small cell. Le khithi isetyenziselwa kuphela ukufumanisa utshintsho oluqhelekileyo kwi-EGFR gene kwizigulane ezinomhlaza wemiphunga we-non-small cell. Iziphumo zovavanyo zezereferensi yezonyango kuphela kwaye akufuneki zisetyenziswe njengesiseko sodwa sonyango olucwangcisiweyo lwezigulane. Iingcali zonyango kufuneka ziqwalasele imeko yesigulana, iimpawu zamayeza, kunye nonyango. Indlela esabela ngayo kunye nezinye izalathisi zovavanyo lwelabhoratri kunye nezinye izinto zisetyenziselwa ukugweba ngokupheleleyo iziphumo zovavanyo.

Itshaneli

I-Reaction Buffer Itshaneli
I-EGFR IC Reaction Buffer Itshaneli ye-FAM
I-L858R Reaction Buffer Itshaneli ye-FAM
I-19del Reaction Buffer Itshaneli ye-FAM
I-T790M Reaction Buffer Itshaneli ye-FAM
I-G719X Reaction Buffer Itshaneli ye-FAM
I-3Ins20 Reaction Buffer Itshaneli ye-FAM
I-L861Q Reaction Buffer Itshaneli ye-FAM
I-S768I Reaction Buffer Itshaneli ye-FAM

Iiparameters zobugcisa

Indawo yokugcina izinto Ulwelo: ≤ -18℃ Ebumnyameni
Beka ubomi kwishelufa Iinyanga ezili-12
Uhlobo lweSibonelelo izicubu ezintsha zethumba, icandelo eliqandisiweyo lesifo, icandelo okanye icandelo lesifo elifakwe kwiparafini, iplasma okanye i-serum
CV <5.0%
I-LoD ukufunyanwa kwesisombululo se-nucleic acid reaction phantsi kwemvelaphi ye-3ng/μL wild-type, kunokufumanisa ngokuzinzileyo izinga lokuguquka kwe-1%;

b) i-nucleic acid reaction Phantsi kwe-1% yenguqu, i-1×103Copies/mL mutation inokubonwa ngokuzinzileyo kwimvelaphi ye-wild-type ye-1×105Copies/mL;

c) Isisombululo sempendulo yesalathiso sangaphakathi sinokubona imveliso yesalathiso i-SW3 enomlinganiselo ophantsi wokufumanisa wesalathiso sangaphakathi seshishini. Xa ikhithi ibona izixhobo zesalathiso somda wokufumanisa wesizwe, izixhobo zesalathiso somda wokufumanisa uguquko lwe-2.5% kunye noguquko lwe-EGFR gene amplification olunotshintsho lwenani lekopi elingu-4 zinokufunyanwa ngokuzinzileyo.

Ukuchaneka Akukho kudibana kwe-DNA ye-genomic yomntu yohlobo lwasendle kunye nezinye iintlobo ze-mutant
Izixhobo Ezisebenzayo Iinkqubo ze-PCR ze-Applied Biosystems 7500 Real-Time,

Iinkqubo ze-PCR ze-Applied Biosystems 7300 Real-Time,

Iinkqubo ze-PCR zeQuantStudio® 5 zeXesha langempela,

Inkqubo ye-PCR yeLightCycler® 480 yeXesha langempela,

Inkqubo ye-PCR ye-BioRad CFX96 yeXesha langempela.

 

Ukuhamba komsebenzi

Ikhithi yokuFumanisa utshintsho lwe-EGFR Gene 29 yabantu (i-Fluorescence PCR)-RUO (2)

 

Ii-reagents ezifunekayo kodwa azibonelelwanga:I-DNase/RNase Free Water, i-anhydrous ethanol. Xa kuvavanywa isampuli yezicubu ezifakwe kwi-paraffin, kucetyiswa ukuba kusetyenziswe i-QIAamp DNA FFPE Tissue Kit (56404) yi-QIAGEN kunye ne-Paraffin-embedded Tissue DNA Rapid Extraction Kit (DP330) yi-Tiangen Biotech (Beijing) Co., Ltd.. Xa kuvavanywa isampuli ye-plasma/serum, kucetyiswa ukuba kusetyenziswe i-Macro & Micro-Test General DNA/RNA Kit (HWTS-3019-50, HWTS-3019-32, HWTS-3019-48, HWTS-3019-96) (engasetyenziswa kunye ne-Macro & Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006C, HWTS-3006B)) yi-Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. okanye i-QIAamp Circulating Nucleic Acid Kit (55114) yi-QIAGEN.

Izinto ezisetyenziswayo ziyafuneka kodwa azibonelelwanga: Iingcebiso ze-DNase/RNase zasimahla, iiglavu ezilahlwayo, ityhubhu ye-DNase/RNase yasimahla ye-Centrifuge, imicu yeetyhubhu ezi-8 ze-PCR, i-centrifuge.


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha uze uwuthumele kuthi